SM-020 Gel 1.0%
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SM-020 Gel 1.0%, covering 2024-05-01 to 2024-05-10. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers [Phase 2]